Management of chronic pediatric uveitis

Related Experiment Video

Updated: Aug 15, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Grace A Levy-Clarke1, Robert B Nussenblatt, Janine A Smith

  • 1Laboratory of Immunology and Division of Clinical Research and Epidemiology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Current Opinion in Ophthalmology
|September 22, 2005
PubMed

Insights

Chronic pediatric uveitis presents diagnostic and management challenges, potentially causing lifelong visual impairment. This review covers recent advances in diagnosing and treating pediatric uveitis, excluding infectious causes.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Rheumatology

Background:

  • Chronic pediatric uveitis poses significant challenges in diagnosis and management.
  • An estimated 25-33% of childhood uveitis cases lead to severe, lifelong visual disability.

Purpose of the Study:

  • To review recent literature on the diagnosis and management of chronic pediatric uveitis.
  • To highlight advances in medical and surgical interventions for pediatric uveitis.

Main Methods:

  • Literature review of recent publications on pediatric uveitis.
  • Focus on non-infectious causes and associated systemic diseases.

Main Results:

  • Recent advances in diagnosing and managing pediatric uveitis are discussed.
  • Key systemic diseases linked to pediatric uveitis include juvenile idiopathic arthritis, sarcoidosis, and Behçet's disease.
  • Treatment strategies for primary ocular conditions like intermediate uveitis and Fuchs' heterochromic iridocyclitis are covered.

Conclusions:

  • Understanding ocular complications aids in tailoring effective treatment regimens.
  • Maximizing visual potential and minimizing disease complications are key goals.
  • Close collaboration among pediatricians, rheumatologists, and ophthalmologists is crucial for comprehensive patient care, including timely surgical intervention and perioperative management of immunosuppressants.
Abstract

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...